Mark Cuban Cost Plus Drug Company Overview

  • Year Founded
  • 2016

Year Founded

  • Status
  • Private

  • Employees
  • 8

Employees

  • Latest Deal Type
  • Seed

  • Latest Deal Amount
  • $1.3M

  • Investors
  • 6

Mark Cuban Cost Plus Drug Company General Information

Description

Developer of low-cost versions of high-cost generic drugs designed to offer affordable medications to its customers. The company's platform gives transparent pricing on all its drugs and offers an antiparasitic drug that helps physicians affordably treat hookworm outbreaks, enabling individuals and healthcare businesses to receive drug formulations at an affordable cost and treat their medical conditions.

Contact Information

Formerly Known As
Osh's Affordable Pharmaceuticals, Osh's Reasonably priced Prescription drugs
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 2909 Taylor Street
  • Suite A
  • Dallas, TX 75226
  • United States
+1 (971)
Primary Industry
Pharmaceuticals
Corporate Office
  • 2909 Taylor Street
  • Suite A
  • Dallas, TX 75226
  • United States
+1 (971)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Mark Cuban Cost Plus Drug Company Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Seed Round 25-Jan-2019 $1.3M Completed Generating Revenue
1. Accelerator/Incubator 22-Aug-2018 Completed Startup
To view Mark Cuban Cost Plus Drug Company’s complete valuation and funding history, request access »

Mark Cuban Cost Plus Drug Company Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Mark Cuban Cost Plus Drug Company Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds
Asymmetry Ventures Venture Capital Minority
C3 Ventures (VC) Venture Capital Minority
Lombardstreet Ventures Venture Capital Minority
Angel (individual) Minority
Maveron Venture Capital Minority
You’re viewing 5 of 6 investors. Get the full list »

Mark Cuban Cost Plus Drug Company FAQs

  • When was Mark Cuban Cost Plus Drug Company founded?

    Mark Cuban Cost Plus Drug Company was founded in 2016.

  • Where is Mark Cuban Cost Plus Drug Company headquartered?

    Mark Cuban Cost Plus Drug Company is headquartered in Dallas, TX.

  • What is the size of Mark Cuban Cost Plus Drug Company?

    Mark Cuban Cost Plus Drug Company has 8 total employees.

  • What industry is Mark Cuban Cost Plus Drug Company in?

    Mark Cuban Cost Plus Drug Company’s primary industry is Pharmaceuticals.

  • Is Mark Cuban Cost Plus Drug Company a private or public company?

    Mark Cuban Cost Plus Drug Company is a Private company.

  • What is Mark Cuban Cost Plus Drug Company’s current revenue?

    The current revenue for Mark Cuban Cost Plus Drug Company is .

  • How much funding has Mark Cuban Cost Plus Drug Company raised over time?

    Mark Cuban Cost Plus Drug Company has raised $1.42M.

  • Who are Mark Cuban Cost Plus Drug Company’s investors?

    Asymmetry Ventures, C3 Ventures (VC), Lombardstreet Ventures, , and Maveron are 5 of 6 investors who have invested in Mark Cuban Cost Plus Drug Company.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process